Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multimodal therapy with morphine and memantine for CRPS
NCT02467556Phase 4Completed
- Sponsor
- Helsinki University Hospital
- Start
- Mar 2011
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of morphine and memantine in Complex Regional Pain Syndrome Type 1 (CRPS-1), sponsored by Helsinki University Hospital. Primary endpoint: Direction of change in patient reported CRPS symptom descriptors at 3 months. Started Mar 2011; status: completed.
02
Drugs
morphinememantine
03
Conditions
Complex Regional Pain Syndrome Type 1 (CRPS-1)
Beyond the preview
Go deeper on NCT02467556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02467556.